Trial Profile
STUDY OF THE EFFECTIVENESS AND CEREBRAL REORGANIZATION AFTER TREATMENT COMBINED WITH DONEPEZILO, INTENSIVE REHABILITATION AND TRANSCRANEAL DIRECT CURRENT STIMULATION IN POSTSTROKE CHRONIC AFASIA
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Aphasia
- Focus Therapeutic Use
- 28 Sep 2018 New trial record